Clinical Trial Update: Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GW786034 in renal cell carcinoma, with Part A radiolabel study and Part B single-dose evaluation. The study status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• GW786034

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Phase 1 | Status: COMPLETED